Matan Arbel-Groissman retweeted
Our best defense against bioterrorism is that biology makes a bad weapon. Malicious actors effectively never choose biology as a tool to cause harm
This review surveys all documented biocrimes since 1763. They found 19 events total in more than 250 years.
99.2% of all biocrime deaths were the actions of the Imperial Army of Japan in World War 2. Exluding those, they found 79 total deaths in total. That's < 1 death per year
Bioterrorism kills fewer people than sharks. Fewer people than falling coconuts. Fewer people than vending machines. It simply isn't a thing
I know that the Killer AI Virus crowd will object that the purpose of biosecurity is to defend against hypothetical future threats, not historically documented threats
But history can still inform our biosecurity policy. If you believe that the world is full of people who want to kill with biology, you are wrong. If you base your biosecurity policy on that belief, you will build the wrong safeguards
A rational, evidence-based biosecurity policy needs to begin from the reality that biology makes a bad weapon and focus on ways to make it an even worse weapon
academic.oup.com/milmed/advaโฆ
Matan Arbel-Groissman retweeted
ืกืืฃ ืกืืฃ ืืจื ืืฉื, ืืืจืื ืืืืคืืื ื ื ืืฉื ืืืืืืจ:
ืฉืืืื ืฉื ืฉืืืฉื ืจืืืืช. ืฉื ืืื ืืืืืืืืื ืืืฉืืืฉื "ืืืืืจืืืืื".
ืืจืื ืืจืืฉืื ื ืืืข ืืืืืืงืื ืืืืื, ืืืชืขืืจืจืื ืืคืขืืืืช ืืขืงืืืช ืืืฉื. ืื ืืคืจืืฉืื ืืืืจ ื ืืืฃ ืืืืื ื ืืืืกืืื (Geosmin).
ืืจืื ืืฉื ื ืืงืืจื ืืฉืื ืื ืืจืืืืืื ืฉืืืคืจืฉื ืืืืื ืขื ืืื ืฆืืืื.
Matan Arbel-Groissman retweeted
ืืื ืืืืจืื ืืืขื ืืื ืื ืืฆืืขื ืืฉืืืช ืืื ืืฆืืข ืืืืื. ืืฆืืื ื ืืฆืจ ืืฉืืขืื ืืคืกืืง ืืืืฆืจ ืืืืจืืคืื ืืจืืง ืืงืจืืช ืืืืจืฃ ืืงืจ ืืืืืฉืื ืฉื ืฆืคืื ืืืจืืงื ืืื ื ืืฉืคืื ืงืจืื ืืืืืื ืฉืื ืืคืืืื ืืื ืืฆืืืืื, ืืืฉื ืืฆืคืฆืคื. ืืื ืืช ืืฆืืข ืืืืื ืฆืจืื ืืืืฆืจ ืืื ืงืฆืจ ืืคื ื ืฉืืขืื ืืช. ืืืืื ืืื ืคืืืื ื ืืฉื ืื ืชืืฆืืื ืื ืืืฉื
Matan Arbel-Groissman retweeted
The first 6 months of a PhD are spent discovering the field. The next 4 years are spent discovering why everyone avoided your particular corner of it.
Matan Arbel-Groissman retweeted
Excited to share our recent publication in @NatureComms!
We started by trying to make people stop associating the money rewards they obtain with irrelevant features of their behavior.
In the first experiment, we used clear instructions framed as a story, and it didn't help...
Matan Arbel-Groissman retweeted
Yep, that's me. you're probably wondering how I got there.
A thread about our newst paper on how transfer of mRNAs through tunneling nanotubes can rescue a disease penotype (in cell culture. but, spoiler, we have new data it also works in mice):
1/12
Complementation of a human disease phenotype by intercellular mRNA transfer dlvr.it/TVMZ7r
Matan Arbel-Groissman retweeted
Replying to @MaximRubinBlum
@MaximRubinBlum
ื"ืจ ืืงืกืื ืจืืืื ืืืื ืืืงืจ ืืช ืคืจืืืช ืืืืืืงืื ืืืจืืื ืืืืคืื ื ืืกืืคืจ ืืืื ืืืกืืจืช ืืื ืก ืฉื ืืืืจื ืืืฉืจืืืืช ืืืืงืจืืืืืืืืื ืฉืืคืจืืื ืืฉ ืืื"ื ืืืืืง ืืืื ืืืืงืจืืืืืื ืืขืืจืื ืืฉืืืืคื ืืคืชืืข ืืืฆืืื ืฉื ืื ืื "ื ืฉื ืืืืืงื ืืื ืืชืืงืื. ืื ืืจืืจ ืื ืืืืืืงืื ืืืื ืืืื ืื ืฉืืื ืฉืืจืืืช ืฉื
Matan Arbel-Groissman retweeted
ืืืืืฉ ืืืืจืื ืืื ืืืฉืืื ืืืจื ืืืฉืืื ืืชืขืฉืืืช ืืชืจืืคืืช ืื ืื ืืชืงืคื ืื ืืืืื ืืชืขืฉืืืช ืืคืืจืื ืืืืื.
ืขืืืืืช ืืืงืืืจื ืืืืืืช ืืืืืชื ืขื ืืืืืฉ ืืื. ืื ืฉืื (ืืืื ืื ื) ืฆืจืืืื ืขืฉืจืช ืืื ืชืฉืืื ืืื ืืืืื ืืืืฉ ืื ืืขืืืื ืงืืจื ืืื.
ืฉืจืฉืืจ ืืฉืืจื ๐งต๐
Matan Arbel-Groissman retweeted
Yes it sucks to spend $200 on a bad antibody. That undoubtedly adds to the cost of doing research. But the total costs of this fraud are *MUCH* larger.
Most people recognize the enormous *time* cost of this fraud - every basic scientist has wasted days trying to make bad antibodies work. But what productive use could that time have been used for? What discoveries *werenโt* made because of this? (Opportunity cost)
Itโs even harder to measure the cost of false positives. How many drug candidates made it to phase 1 testing because of bad antibodies? Is this why so many drugs fail in phase 1?
How many patients were harmed by ineffective therapies developed using bad antibodies? (Human cost)
How many hundreds of billions do failed phase 1 studies add to the cost of drug development, and indirectly to overall healthcare costs?
Weโre all paying for this fraud whether youโve ever pipetted or not. The companies that are deliberately selling bad antibodies should be held accountable for these costs.
Matan Arbel-Groissman retweeted
Toxin-Antitoxin systems are thought to induce death or dormancy under some stress conditions.
Focusing on the well studied MazEF system, we now show that this is not always the case.
biorxiv.org/content/10.64898โฆ
Matan Arbel-Groissman retweeted
ืืฉ ืื ืืืจื ืกืืคืจ ืืฉืจืื ืืช, ืฉืืืืจืช ืืืจืฅ ืขืื ืืืืฉืืื ืืคืืกื ืืืจืืืจื ืืืืคืฉืช ืขืืืื!
ืืฉ ืื ื ืกืืื ืืืืจืื ืฉื ืืืืืืืื ืืื ืืืงืจ ืคืืจืืืช, ืืคืืื ืืืงื ืืืกืืื ืื ืืืืจืืืจืืืืื, ืืืืื ืืืืช, ืืืงืจืืกืงืืคืื, ืืืืืณืื ื ืืื ืืื ืืงืืช ืฉืื ืืช ืืืืืงืืืจืืช
ืืืื ื ืืขืืืื ืืืฆืืืจ
ืื ืืชื ืืืืจืื ืืืจืืช ืฉืืืคืฉืืช ืืฉืื ืืงืืฉืืจ
Matan Arbel-Groissman retweeted
1/8 Thrilled to share that our new paper is officially out in @Nature today!
nature.com/articles/s41586-0โฆ
Matan Arbel-Groissman retweeted
ืฉื ื ืืืืช ืืจืง ืฆื ื"ื. ื ื ืกื ืืืืื ืืฉืื ืืืืกืื.
ืืืืืืืฆืื ืืื ื ืชืืืื ืชืืื ื, ืืืื ื ืืจืฉืืช ืื ืืขืชืื ืืืืช ืืืืืื ื ืฉื ืื ืืื ืืกืืืจ ืืขืื. ืื ืงืจื ืขื ืืืืืจ ืืื ืฉื ืืขืื-ืืืืืืืช.
ืืืืืจ ืืื ืฉื ืืื ืืื ืคืฉืื ืืืขืื: ืื ืืืืจื ืืืื ืืื-ืืืจื ืื ืืืืืื, ืืชืจืืื ืืืืฆื (ืืืื), ืืืฉืื ืืฉื ืืขืืจืง ืืจืืฉื,
Matan Arbel-Groissman retweeted
1/ Lab automation is insanely mispriced.
Today I visited a London-based biomaterials startup running large-scale bacterial screens.
They use a colony picker that costs $95,000
Matan Arbel-Groissman retweeted
ืงืฆืช ืืืข ืืืกืงืคืืื:
ืืฉื ื ืืืืืืืื ืฉื ืงืจืืื PFAS ืฉืืื ื ืืฉืืืืฉ ืชืขืฉืืืชื ื ืจืื. ืืคืืื ืืื ืืื ืืื. ืืืืืื ืฉืื ื"ื ืืฆืืืื, ืืื ืืฉืืจ ืืืื ืงืฉืจื ืคืืื-ืคืืืืืจ, ืื ื ืืฉืืื ื"ืืืืืืื ื ืฆื" ืฉืืชืคืจืงืื ืืื ืืื ืืืืืืื ืื ืืช ืืกืืืื. ืืืืงื ืืฉ ืืื ืืืฆืืช ืืืื ืฉื 8 ืฉื ืื ืืืืฃ ืฉืื ื. ืืืงื ืงืฉืืจืื ืืืืืืช ืื ืื
Matan Arbel-Groissman retweeted
Iโve seen alot of posts recently about pancreatic cancer being โcuredโ in mice. Just a general reminder of something that is currently hung in my office:
Matan Arbel-Groissman retweeted
ืืืืืจ ืืืืฉ ืฉืื ื ืขื ืชืืจืฉืชืืืช ืชืืืืช ืืืืื ืคืืจืกื ื-@ScienceMagazine ืืืื ืืื ืืขื ืืฉืืคื ืชืงืฉืืจืชืืช.
ืืืืข ืืขืช ืืฉืจืฉืืจ ืืขืืจืืช!
ืืืฉื ืขืฉืืจืื, ืฉืื ืืงืื ืฆื ืืืก ืฉืื ืืืงื ืืกืืืจื ืจืง ื-20-25% ืืืืืืืื ืืืฉื ืืืืื ืืื ืื ืฉืื. ืืืืจ ืฉืืงืื ื ืืืฉืืื "ืชืืืชื ืืืฆืื ืืช", ืืฆืื ื ืฉืืืกืคืจ ืงืืคืฅ ื-50%.
Matan Arbel-Groissman retweeted
It just seems implausible this is what we are made of, essentially, nanotechnology about a billion years beyond anything we can design or make ourselves.
Matan Arbel-Groissman retweeted
Our new paper on reassessing the heritability of human lifespan is out in @ScienceMagazine! ๐งฌ
For decades, the consensus has been that genetics explains just 20โ25% of lifespan differences. We found that after accounting for extrinsic mortality, that number jumps to ~50%.
A ๐งต

































